Vestal Point Capital, LP Portfolio Holdings

Vestal Point Capital, LP

  • $1.4 Trillion
  • Q1 2025

Vestal Point Capital, LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $1.4 Trillion distributed in 63 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $157B, Cytokinetics Inc with a value of $104B, Insmed Inc with a value of $82B, Nuvalent, Inc. with a value of $76.2B, and Vera Therapeutics, Inc. with a value of $60.1B.

Examining the 13F form we can see an decrease of $286B in the current position value, from $1.69T to 1.4T.

Vestal Point Capital, LP is based out at New York, NY

Below you can find more details about Vestal Point Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $1.4 Trillion
Healthcare: $86.9 Billion

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$13.1B
$82 Billion 5.86% of portfolio
1,075,000
Q1 2025 Added 19.44%
$146B
$25.6 Billion 1.83% of portfolio
125,000
Q1 2025 New

Summary

  • Portfolio
  • No. of Stocks 63
  • Current Value $1.4 Trillion
  • Prior Value $1.69 Trillion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 13 stocks
  • Additional Purchases 27 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 13 stocks
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email